ADC Therapeutics (ADCT) Non-Current Assets (2019 - 2026)
ADC Therapeutics (ADCT) reported Non-Current Assets of $17.67 million for Q2 2026, up 529.8% from $2.81 million a year earlier and up 20.0% from the prior quarter.
ADC Therapeutics (ADCT) Non-Current Assets (2019 - 2026) Analysis & Trends
At the end of FY2025, ADC Therapeutics posted Non-Current Assets of $16.82 million, down 45.3% from FY2024.
- Non-Current Assets has a five-year compound annual growth rate of -23.3% (FY2020 to FY2025).
- By year, Non-Current Assets came in at $30.73 million in FY2024 (+66.2%), $18.49 million in FY2023 (-66.9%), $55.88 million in FY2022 (-39.8%) and $92.79 million in FY2021 (+46.7%).
- The Q2 2026 figure ranks as the highest quarterly Non-Current Assets since Q4 2024.
- Year over year, Non-Current Assets gained in three of the last eight quarters, with growth averaging 35.6%.
- The high point for year-over-year Non-Current Assets in five years was Q2 2026 (growth of 529.8%); the low point was Q3 2025 (a decline of 83.8%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $14.73 million (Q1 2026), $16.82 million (Q4 2025) and $2.61 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,135.99 Bn | 1,104.58 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 616.90 Bn | 535.42 Bn | 17.26 Bn | 141.29 Bn |
| 3 | AbbVie | 501.56 Bn | 474.68 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 367.41 Bn | 321.79 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 261.45 Bn | 235.13 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 236.48 Bn | 191.88 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 190.56 Bn | 164.76 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 169.46 Bn | 116.11 Bn | 10.94 Bn | 159.77 Bn |
| 10 | ADC Therapeutics | 232.52 Mn | -713.67 Mn | 16.90 Mn | 17.67 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.67 Mn |
| Mar 31, 2026 | 14.73 Mn |
| Dec 31, 2025 | 16.82 Mn |
| Sep 30, 2025 | 2.61 Mn |
| Jun 30, 2025 | 2.81 Mn |
| Mar 31, 2025 | 14.55 Mn |
| Dec 31, 2024 | 30.73 Mn |
| Sep 30, 2024 | 16.07 Mn |
| Jun 30, 2024 | 16.42 Mn |
| Mar 31, 2024 | 17.76 Mn |
| Dec 31, 2023 | 18.49 Mn |
| Sep 30, 2023 | 91.30 Mn |
| Jun 30, 2023 | 94.49 Mn |
| Mar 31, 2023 | 87.67 Mn |
| Dec 31, 2022 | 55.88 Mn |
| Sep 30, 2022 | 93.66 Mn |
| Jun 30, 2022 | 96.02 Mn |
| Mar 31, 2022 | 94.18 Mn |
| Dec 31, 2021 | 92.79 Mn |
| Sep 30, 2021 | 69.57 Mn |
ADC Therapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=ADCT&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "ADCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=ADCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();